Cempra appoints John Bluth as executive vice president
Prior to joining Cempra, Mr. Bluth headed investor relations and corporate communications for two of Silicon Valley’s leading biotechnology companies, CV Therapeutics, which was acquired in 2009, and Aviron, which was acquired in 2002.
Before joining Aviron, Mr. Bluth led the west coast healthcare practice for Fleishman-Hillard, an international public relations firm.
From 2009-2012, Mr. Bluth was senior vice president of investor relations and group communications at German-based Elster Group, one of the world’s largest electricity, gas and water measurement and control providers.
Mr. Bluth served as a member of Elster’s group executive board and built the investor relations and corporate communications functions for the company through its initial public offering in 2009. Elster was acquired in 2012.
From 2012 through mid-2016, Mr. Bluth was senior vice president of investor relations and corporate communications and served on the executive committee at PowerSecure International,.
Mr. Bluth holds a Bachelor’s degree in physiology from Cornell University. ■
LATEST MOVES FROM North Carolina
- Nucor elects General Lloyd J. Austin III (Ret) as director
- Jeld-Wen Holding appoints William Banholzer to board
- QuintilesIMS appoints Colleen Goggins to board
- G1 Therapeutics appoints Sir Andrew Witty to board
- Select Bancorp promotes Lynn H. Johnson to COO
More inside POST